SCHEMBL2491429

SCHEMBL2491429

Cc1c(CN2CCNCC2)ccc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
SIGMAR1 Q99720 1/20 0.47
HTR7 P34969 5/20 0.42
CYP1A2 P05177 1/20 0.42
CHRM2 P08172 1/20 0.42
SLC6A4 P31645 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR6 P50406 3/20 0.41
HTR1A P08908 1/20 0.41
HTR2A P28223 1/20 0.41
HTR5A P47898 1/20 0.41
APOBEC3A P31941 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
DRD4 P21917 1/20 0.39
MAPT P10636 1/20 0.39
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2494582 0.87 ALDH1A1 (0.47) LMNASIGMAR1HTR7DRD2DRD3
SCHEMBL2491953 0.86 ALDH1A1 (0.49) LMNAHTR7CYP1A2MAPTCD274
SCHEMBL2491596 0.83 SIGMAR1 (0.47) LMNASIGMAR1HTR7CYP1A2CHRM2
SCHEMBL2490243 0.83 CYP1A2 (0.58) LMNASIGMAR1HTR7CYP1A2CHRM2
SCHEMBL2472212 0.77 HTR7 (0.64) LMNASIGMAR1HTR7SLC6A4HTR6
SCHEMBL30616744 0.77 HTR7 (0.64) LMNASIGMAR1HTR7SLC6A4HTR6
SCHEMBL17276426 0.74 LMNA (0.63) LMNASIGMAR1HTR7CYP1A2CHRM2
SCHEMBL7097403 0.72 HTR7 (0.62) LMNASIGMAR1HTR7HTR6DRD2
SCHEMBL19186952 0.72 LMNA (0.60) LMNASIGMAR1CYP1A2CHRM2SLC6A4
SCHEMBL3962172 0.71 LMNA (0.73) LMNASIGMAR1CYP1A2CHRM2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH LMNA 2547/4885SIGMAR1 394/4885HTR7 241/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 LMNA 2843/4885SIGMAR1 491/4885HTR7 164/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R LMNA 2187/4885SIGMAR1 486/4885HTR7 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.